Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122987103 | 12298710 | 3 | F | 20160328 | 20160711 | 20160425 | 20160722 | EXP | JP-ALXN-A201602271AA | ALEXION | 17.00 | YR | M | Y | 0.00000 | 20160722 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122987103 | 12298710 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | 1350 | MG | AE3116D01 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | |||
| 122987103 | 12298710 | 2 | C | ADRENAL CORTEX EXTRACT | 2 | Unknown | UNK | 0 | |||||||||||
| 122987103 | 12298710 | 3 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 250 MG, QD | 0 | 250 | MG | QD | |||||||
| 122987103 | 12298710 | 4 | C | AMBISOME | AMPHOTERICIN B | 1 | Intravenous drip | 200 MG, QD | 0 | 200 | MG | INJECTION | QD | ||||||
| 122987103 | 12298710 | 5 | C | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous drip | 20 MG, TID | 0 | 20 | MG | INJECTION | TID | ||||||
| 122987103 | 12298710 | 6 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 500 MG, BID | 0 | 500 | MG | CAPSULE | BID | ||||||
| 122987103 | 12298710 | 7 | C | VFEND | VORICONAZOLE | 1 | Intravenous drip | 160 MG, QD | 0 | 160 | MG | INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122987103 | 12298710 | 1 | Haemolytic uraemic syndrome |
| 122987103 | 12298710 | 2 | Product used for unknown indication |
| 122987103 | 12298710 | 3 | Bronchopulmonary aspergillosis |
| 122987103 | 12298710 | 4 | Bronchopulmonary aspergillosis |
| 122987103 | 12298710 | 5 | Chronic graft versus host disease |
| 122987103 | 12298710 | 6 | Chronic graft versus host disease |
| 122987103 | 12298710 | 7 | Bronchopulmonary aspergillosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122987103 | 12298710 | OT |
| 122987103 | 12298710 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122987103 | 12298710 | Bronchopulmonary aspergillosis | |
| 122987103 | 12298710 | Drug ineffective | |
| 122987103 | 12298710 | Pulmonary alveolar haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122987103 | 12298710 | 1 | 20160323 | 20160330 | 0 | |
| 122987103 | 12298710 | 2 | 20160322 | 0 | ||
| 122987103 | 12298710 | 3 | 20160318 | 20160320 | 0 | |
| 122987103 | 12298710 | 4 | 20160321 | 20160418 | 0 | |
| 122987103 | 12298710 | 5 | 20160218 | 20160418 | 0 | |
| 122987103 | 12298710 | 6 | 20160218 | 20160320 | 0 | |
| 122987103 | 12298710 | 7 | 20160328 | 20160418 | 0 |